{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:23:02Z","timestamp":1787854982808,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"DOI":"10.7759\/cureus.115309","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:50:06Z","timestamp":1787853006000},"source":"Crossref","is-referenced-by-count":0,"title":["Carcinoid Heart Disease Presenting as Cardiogenic Shock: A Case Report"],"prefix":"10.7759","author":[{"given":"Pedro","family":"Duque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisseth","family":"Salazar-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Alexander","family":"Pantoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar J","year":"2017","unstructured":"Davar J, Connolly HM, Caplin ME, et al.. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol. 2017, 69:1288-304. 10.1016\/j.jacc.2016.12.030","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1353612","article-title":"A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease","volume":"11","author":"Namkoong J","year":"2024","unstructured":"Namkoong J, Andraweera PH, Pathirana M, et al.. A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease. Front Cardiovasc Med. 2024, 11:1353612. 10.3389\/fcvm.2024.1353612","journal-title":"Front Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI","volume":"3","author":"Bhattacharyya S","year":"2010","unstructured":"Bhattacharyya S, Toumpanakis C, Burke M, Taylor AM, Caplin ME, Davar J. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI. Circ Cardiovasc Imaging. 2010, 3:103-11. 10.1161\/CIRCIMAGING.109.886846","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2024.15.6.3","article-title":"Carcinoid heart disease","volume":"15","author":"Kuhnly N","year":"2024","unstructured":"Kuhnly N, Coviello JS, Kobza CA, Patel DA, Lagoy JS, Cyr ML. Carcinoid heart disease. J Adv Pract Oncol. 2024, 15:378-86. 10.6004\/jadpro.2024.15.6.3","journal-title":"J Adv Pract Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka PA","year":"1993","unstructured":"Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993, 87:1188-96. 10.1161\/01.cir.87.4.1188","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio PA","year":"1995","unstructured":"Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation. 1995, 92:790-5. 10.1161\/01.cir.92.4.790","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13262","article-title":"Carcinoid heart disease in patients with midgut neuroendocrine tumours","volume":"35","author":"Delhomme C","year":"2023","unstructured":"Delhomme C, Walter T, Arangalage D, et al.. Carcinoid heart disease in patients with midgut neuroendocrine tumours. J Neuroendocrinol. 2023, 35:e13262. 10.1111\/jne.13262","journal-title":"J Neuroendocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-17-6562","article-title":"Carcinoid heart disease: review of current knowledge","volume":"46","author":"Ram P","year":"2019","unstructured":"Ram P, Penalver JL, Lo KB, Rangaswami J, Pressman GS. Carcinoid heart disease: review of current knowledge. Tex Heart Inst J. 2019, 46:21-7. 10.14503\/THIJ-17-6562","journal-title":"Tex Heart Inst J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26528","article-title":"Hedinger syndrome: a rare cardiac manifestation of carcinoid syndrome","volume":"14","author":"Ghukasyan H","year":"2022","unstructured":"Ghukasyan H. Hedinger syndrome: a rare cardiac manifestation of carcinoid syndrome. Cureus. 2022, 14:e26528. 10.7759\/cureus.26528","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2020.08.026","article-title":"Carcinoid crisis-induced acute systolic heart failure","volume":"2","author":"Maddali MV","year":"2020","unstructured":"Maddali MV, Chiu C, Cedarbaum ER, et al.. Carcinoid crisis-induced acute systolic heart failure. JACC Case Rep. 2020, 2:2068-71. 10.1016\/j.jaccas.2020.08.026","journal-title":"JACC Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd10100413","article-title":"Hedinger syndrome-lessons learnt: a single-center experience","volume":"10","author":"El Gabry M","year":"2023","unstructured":"El Gabry M, Arends S, Shehada SE, Lahner H, Kamler M, Wendt D, Spetsotaki K. Hedinger syndrome-lessons learnt: a single-center experience. J Cardiovasc Dev Dis. 2023, 10:10.3390\/jcdd10100413","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad126","article-title":"Carcinoid heart disease management: a multi-disciplinary collaboration","volume":"28","author":"Das S","year":"2023","unstructured":"Das S, Stockton SS, Hassan SA. Carcinoid heart disease management: a multi-disciplinary collaboration. Oncologist. 2023, 28:575-83. 10.1093\/oncolo\/oyad126","journal-title":"Oncologist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharyya S","year":"2011","unstructured":"Bhattacharyya S, Toumpanakis C, Chilkunda D, Caplin ME, Davar J. Risk factors for the development and progression of carcinoid heart disease. Am J Cardiol. 2011, 107:1221-6. 10.1016\/j.amjcard.2010.12.025","journal-title":"Am J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.05.047","article-title":"Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease","volume":"102","author":"Bhattacharyya S","year":"2008","unstructured":"Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J. Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease. Am J Cardiol. 2008, 102:938-42. 10.1016\/j.amjcard.2008.05.047","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.7047","article-title":"Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor","volume":"27","author":"Korse CM","year":"2009","unstructured":"Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor. J Clin Oncol. 2009, 27:4293-9. 10.1200\/JCO.2008.18.7047","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2025.05.013","article-title":"Echocardiographic evaluation of carcinoid heart disease","volume":"38","author":"Ayoub C","year":"2025","unstructured":"Ayoub C, Scalia IG, Luis SA, et al.. Echocardiographic evaluation of carcinoid heart disease. J Am Soc Echocardiogr. 2025, 38:775-93. 10.1016\/j.echo.2025.05.013","journal-title":"J Am Soc Echocardiogr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000360767","article-title":"Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease","volume":"99","author":"Dobson R","year":"2014","unstructured":"Dobson R, Cuthbertson DJ, Jones J, et al.. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease. Neuroendocrinology. 2014, 99:85-93. 10.1159\/000360767","journal-title":"Neuroendocrinology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease","volume":"34","author":"Grozinsky-Glasberg S","year":"2022","unstructured":"Grozinsky-Glasberg S, Davar J, Hofland J, et al.. European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease. J Neuroendocrinol. 2022, 34:e13146. 10.1111\/jne.13146","journal-title":"J Neuroendocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin ME","year":"2014","unstructured":"Caplin ME, Pavel M, \u0106wik\u0142a JB, et al.. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014, 371:224-33. 10.1056\/NEJMoa1316158","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.014","article-title":"Early and late outcomes of surgical treatment in carcinoid heart disease","volume":"66","author":"Connolly HM","year":"2015","unstructured":"Connolly HM, Schaff HV, Abel MD, et al.. Early and late outcomes of surgical treatment in carcinoid heart disease. J Am Coll Cardiol. 2015, 66:2189-96. 10.1016\/j.jacc.2015.09.014","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/502660-carcinoid-heart-disease-presenting-as-cardiogenic-shock-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:50:07Z","timestamp":1787853007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/502660-carcinoid-heart-disease-presenting-as-cardiogenic-shock-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.115309","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}